Erratum: c-Myc-deficient B lymphocytes are resistant to spontaneous and induced cell death (Cell Death and Differentiation (2004) vol. 11 (61-68) 10.1038/sj.cdd.4401319);c-Myc-deficient B lymphocytes are resistant to spontaneous and induced cell death

Cell Death and Differentiation

Volumn 11, Issue 1, 2004, Pages 61-68

  de Alborán, I Moreno ^a   Baena, E ^a   Martinez A, C ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Apoptosis; c myc; CD95; CD95L; Cre; Flox; Staurosporine

Indexed keywords

CRE RECOMBINASE; FAS ANTIGEN; GREEN FLUORESCENT PROTEIN; LYMPHOCYTE SURFACE MARKER; MYC PROTEIN; STAUROSPORINE;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL DEATH; CONTROLLED STUDY; DRUG RESISTANCE; GENE OVEREXPRESSION; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION;

ANIMALIA;

EID: 1642555717     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401319     Document Type: Erratum

References (38)

1. Askew DS, Ashmun RA, Simmons BC and Cleveland JL (1991) Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6: 1915-1922
2. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-128
3. Waters CM, Littlewood TD, Hancock DC, Moore JP and Evan GI (1991) c-myc protein expression in untransformed fibroblasts. Oncogene 6: 797-805
4. Facchini LM and LZ P (1998) The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. FASEB J 12: 633-651
5. Dang CV (1999) c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 19: 1-11
6. Zimmerman Ka and Alt FW (1990) Expression and function of myc family genes. Crit Rev Oncog 2: 75-95
7. Campisi J, Gray HE, Pardee AB, Dean M and Sonenshein GE (1984) Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation. Cell 36: 241-247
8. Kelly K, Cochran BH, Stiles CD and Leder P (1983) Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35 (Part 2): 603-610
9. Thompson EB (1998) The many roles of c-Myc in apoptosis. Annu Rev Physiol 60: 575-600
10. Hueber AO, Zornig M, Lyon D, Suda T, Nagata S and Evan GI (1997) Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. Science 278: 1305-1309
11. Krammer PH (2000) CD95's deadly mission in the immune system. Nature 407: 789-795
12. Shi Y, Glynn JM, Guilbert LJ, Cotter TG, Bissonnette RP and Green DR (1992) Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 257: 212-214
13. Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR L, DH WC and DR G (1995) Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373: 441-444
14. Dhein J, Walczak H, Baumler C, Debatin KM and PH K (1995) Autocrine T-cell suicide mediated by APO-1/. Nature 373: 438-441
15. Ju ST, Panka DJ, Cui H, Ettinger R, el-Khatib M, Sherr DH, Stanger BZ and Marshak-Rothstein A (1995) Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373: 444-448
16. Genestier L, Kasibhatla S, Brunner T and Green DR (1999) Transforming growth factor beta1 inhibits fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc (in process citation). J Exp Med 189: 231-239
17. Brunner T, Kasibhatla S, Pinkoski MJ, Frutschi C, Yoo NJ, Echeverri F, Mahboubi A and Green DR (2000) Expression of Fas ligand in activated T cells is regulated by c-Myc. J Biol Chem 275: 9767-9772
18. Sonenshein GE (1997) Down-modulation of c-myc expression induces apoptosis of B lymphocyte models of tolerance via clonall deletion. J Immunol 158: 1994-1997
19. Wu M, Arsura M, Bellas RE, FitzGerald MJ, Lee H, Schauer SL, Sherr DH and Sonenshein GE (1996) Inhibition of c-myc expression induces apoptosis of WEHI 231 murine B cells. Mol Cell Biol 16: 5015-5025
20. DeFranco AL, Mittelstadt PR, Blum JH, Stevens TL, Law DA, Chan VW, Foy SP, Datta SK and Matsuuchi L (1994) Mechanism of B cell antigen receptor function: transmembrane signaling and triggering of apoptosis. Adv Exp Med Biol 365: 9-22
21. Rathmell JC, Townsend SE, Xu JC, Flavell RA and CC G (1996) Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 87: 319-329
22. Rathmell JC, Cooke MP, Ho WY, Grein J, Townsend SE, Davis MM and Goodnow CC (1995) CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature 376: 181-184
23. Rothstein TL, Wang JK, Panka DJ, Foote LC, Wang Z, Stanger B, Cui H, Ju ST and Marshak-Rothstein A (1995) Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor. Nature 374: 163-165
24. Davis AC, Wims M, Spotts GD, Hann SR and Bradley A (1993) A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev 7: 671-682
25. de Alboran IM, O'Hagan RC, Gartner F, Malynn B, Davidson L, Rickert R, Rajewsky K, DePinho RA and Alt FW (2001) Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity 14: 45-55
26. Mao X, Fujiwara Y, Chapdelaine A, Yang H and Orkin SH (2001) Activation of EGFP expression by Cre-mediated excision in a new ROSA26 reporter mouse strain. Blood 97: 324-326
27. Friedrich G and Soriano P (1991) Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Genes Dev 5: 1513-1523
28. Juin P, Hueber AO, Littlewood T and Evan G (1999) c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev 13: 1367-1381
29. Foote LC, Howard RG, Marshak-Rothstein A and Rothstein TL (1996) IL-4 induces Fas resistance in B cells. J Immunol 157: 2749-2753
30. Foote LC, Marshak-Rothstein A and Rothstein TL (1998) Tolerant B lymphocytes acquire resistance to Fas-mediated apoptosis after treatment with interleukin 4 but not after treatment with specific antigen unless a surface immunoglobulin threshold is exceeded. J Exp Med 187: 847-853
31. Tamaoki T, Nomoto H, Takahashi I, Kato Y, Morimoto M and Tomita F (1986) Staurosporine, a potent inhibitor of phospholipid/Ca++ dependent protein kinase. Biochem Biophys Res Commun 135: 397-402
32. Malyguine A, Derby E, Brooks A, Reddy V, Baseler M and Sayers T (2002) Study of diverse mechanisms of cell-mediated cytotoxicity in gene-targeted mice using flow cytometric cytotoxicity assay. Immunol Lett 83: 55-59
33. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE and Tschopp J (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388: 190-195
34. Delneste Y, Jeannin P, Sebille E, Aubry JP and Bonnefoy JY (1996) Thiols prevent Fas (CD95)-mediated T cell apoptosis by down-regulating membrane Fas expression. Eur J Immunol 26: 2981-2988
35. Los M, Van de Craen M, Penning LC, Schenk H, Westendorp M, Baeuerle PA, Droge W, Krammer PH, Fiers W and Schulze-Osthoff K (1995) Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature 375: 81-83
36. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG and Earnshaw WC (1994) Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371: 346-347
37. Vooijs M, Jonkers J and Berns A (2001) A highly efficient ligand-regulated Cre recombinase mouse line shows that LoxP recombination is position dependent. EMBO Rep 2: 292-297
38. Lundy SK and Boros DL (2002) Fas ligand-expressing B-1a lymphocytes mediate CD4(+)-T-cell apoptosis during schistosomal infection: induction by interleukin 4 (IL-4) and IL-10. Infect Immun 70: 812-819